We are live on
!
Find out more
FGP
Freestone Grove Partners Portfolio holdings
AUM
$14.2B
1-Year Est. Return
24.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+24.58%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.16B
AUM Growth
–
Cap. Flow
+$8.32B
Cap. Flow
% of AUM
101.89%
Top 10 Holdings %
Top 10 Hldgs %
19.11%
Holding
569
New
569
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$694M |
| 2 |
ExxonMobil
XOM
|
+$113M |
| 3 |
ConocoPhillips
COP
|
+$105M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$103M |
| 5 |
Becton Dickinson
BDX
|
+$101M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.73% |
| 2 | Financials | 16.49% |
| 3 | Industrials | 13.44% |
| 4 | Healthcare | 12.86% |
| 5 | Energy | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Robert Half
RHI
$3.7B
| $250K | ﹤0.01% |
+3,544
| New | +$253K |
|
502
Yeti Holdings
YETI
$3.77B
| $249K | ﹤0.01% |
+6,463
| New | +$257K |
|
503
Lindsay Corp
LNN
$1.16B
| $246K | ﹤0.01% |
+2,077
| New | +$258K |
|
|
DCH
504
Dauch Corp
DCH
$1.33B
| $245K | ﹤0.01% |
+41,998
| New | +$263K |
|
505
Fair Isaac
FICO
$28.7B
| $243K | ﹤0.01% |
+122
| New | +$261K |
|
506
Vishay Intertechnology
VSH
$5.94B
| $242K | ﹤0.01% |
+14,287
| New | +$251K |
|
507
Columbus McKinnon
CMCO
$465M
| $242K | ﹤0.01% |
+6,494
| New | +$236K |
|
508
Transmedics
TMDX
$2.44B
| $241K | ﹤0.01% |
+3,865
| New | +$360K |
|
509
Praxis Precision Medicines
PRAX
$9B
| $237K | ﹤0.01% |
+3,080
| New | +$223K |
|
510
Ralph Lauren
RL
$22.4B
| $235K | ﹤0.01% |
+1,018
| New | +$217K |
|
511
Madison Square Garden
MSGE
$3.63B
| $233K | ﹤0.01% |
+6,552
| New | +$253K |
|
512
Commault Systems
CVLT
$5.89B
| $232K | ﹤0.01% |
+1,540
| New | +$248K |
|
513
Jack in the Box
JACK
$277M
| $232K | ﹤0.01% |
+5,562
| New | +$257K |
|
|
CHX
514
DELISTED
ChampionX
CHX
| $230K | ﹤0.01% |
+8,461
| New | +$252K |
|
|
HES
515
DELISTED
Hess
HES
| $229K | ﹤0.01% |
+1,725
| New | +$241K |
|
516
BioCryst Pharmaceuticals
BCRX
$2.39B
| $228K | ﹤0.01% |
+30,313
| New | +$230K |
|
517
Viking Therapeutics
VKTX
$4.05B
| $224K | ﹤0.01% |
+5,572
| New | +$318K |
|
518
TG Therapeutics
TGTX
$8.42B
| $224K | ﹤0.01% |
+7,433
| New | +$213K |
|
519
Kadant
KAI
$3.71B
| $223K | ﹤0.01% |
+646
| New | +$234K |
|
520
Upbound Group
UPBD
$1.23B
| $221K | ﹤0.01% |
+7,569
| New | +$235K |
|
521
Green Plains
GPRE
$1.2B
| $219K | ﹤0.01% |
+23,063
| New | +$260K |
|
522
Pegasystems
PEGA
$4.36B
| $219K | ﹤0.01% |
+4,690
| New | +$201K |
|
|
GRAL
523
GRAIL Inc
GRAL
$2.97B
| $217K | ﹤0.01% |
+12,163
| New | +$198K |
|
524
Bank OZK
OZK
$5.49B
| $213K | ﹤0.01% |
+4,788
| New | +$219K |
|
525
Napco Security Technologies
NSSC
$1.28B
| $213K | ﹤0.01% |
+5,980
| New | +$229K |
|
Similar funds
BIP
SSA
X
CM
BBVA
IFP
TI
Freestone Grove Partners's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for Freestone Grove Partners, which disclosed 569 positions worth $8.16B. Its ten largest holdings account for 19% of the portfolio.
Its largest position is iShares Core S&P 500 ETF: 1,173,000 shares worth $691M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, followed by Financials and Industrials.
- Freestone Grove Partners's largest Q4 2024 buy was iShares Core S&P 500 ETF: 1,173,000 shares worth $691M.
- Freestone Grove Partners's ten largest holdings make up 19% of its $8.16B portfolio in Q4 2024.
- Freestone Grove Partners disclosed 569 positions in Q4 2024, its first 13F filing on record.
Based on Freestone Grove Partners's 13F filing for Q4 2024, filed 14 Feb 2025.